Conducting a quality study of the medicinal product - Vortioxetine

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509946-36-00

Acronym

CBF23001

Enrollment

Registered

2024-04-01

Start date

2024-06-29

Completion date

2024-08-15

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No therapeutic indication in the current trial with healthy volunteers. The intended indication is for the treatment of major depressive episodes in adults

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Countries

Bulgaria

Outcome results